
Puma Biotechnology Inc
NASDAQ:PBYI

Intrinsic Value
The intrinsic value of one
PBYI
stock under the Base Case scenario is
5.514
USD.
Compared to the current market price of 3.235 USD,
Puma Biotechnology Inc
is
Undervalued by 41%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Puma Biotechnology Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Puma Biotechnology Inc
Balance Sheet Decomposition
Puma Biotechnology Inc
Current Assets | 132.5m |
Cash & Short-Term Investments | 93.2m |
Receivables | 25.2m |
Other Current Assets | 14.2m |
Non-Current Assets | 63.7m |
PP&E | 4.2m |
Intangibles | 48.7m |
Other Non-Current Assets | 10.8m |
Free Cash Flow Analysis
Puma Biotechnology Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Puma Biotechnology Inc
Revenue
|
232.7m
USD
|
Cost of Revenue
|
-64.2m
USD
|
Gross Profit
|
168.5m
USD
|
Operating Expenses
|
-131.2m
USD
|
Operating Income
|
37.2m
USD
|
Other Expenses
|
818k
USD
|
Net Income
|
38.1m
USD
|
PBYI Profitability Score
Profitability Due Diligence
Puma Biotechnology Inc's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Score
Puma Biotechnology Inc's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
PBYI Solvency Score
Solvency Due Diligence
Puma Biotechnology Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Score
Puma Biotechnology Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PBYI Price Targets Summary
Puma Biotechnology Inc
According to Wall Street analysts, the average 1-year price target for
PBYI
is 5.61 USD
with a low forecast of 4.04 USD and a high forecast of 7.35 USD.
Dividends
Current shareholder yield for PBYI is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
PBYI
stock under the Base Case scenario is
5.514
USD.
Compared to the current market price of 3.235 USD,
Puma Biotechnology Inc
is
Undervalued by 41%.